No Data Yet
Zacks Investment Research highlighted five value stocks on December 16, with Keros Therapeutics and StoneCo leading with projected 3-5 year EPS growth rates of 36.5% and 30.3%, respectively.
The U.S. Federal Reserve’s latest interest rate cut to a 3.50%-3.75% range presents a significant challenge to Circle’s revenue model, which is highly dependent on interest earned from USDC reserves. This forces the company to accelerate USDC circulation and platform adoption to maintain growth, even as sophisticated competitors like Ant International advance their own blockchain-based liquidity solutions with major banks.